ALCMI-005: Pembrolizumab and Epacadostat in Treating Patients With Extensive Stage Small Cell Lung Cancer
Clinical trial NCT03402880 · WITHDRAWN
Trial details
- NCT number
- NCT03402880
- Sponsor
- City of Hope Medical Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-01
- Primary completion
- 2018-10-03
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.